Portfolio Lab

Health Catalyst, Inc.

  • Stock
  • Ticker HCAT
  • ISIN US42225T1079
  • Nasdaq

Technology · Software and IT services · USA

$1.31 +1.55%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Health Catalyst, Inc. since 07/2019, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

HCATGlobal equities (VT)

$10,000 grew to $249. Global equities (VT): $14,653.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −98.3% in 04/2026, measured from the peak in 06/2021. The old peak has not been reached again yet.

1-year return
−35.5%
5-year return p.a.
−51.0%
Return p.a. since 07/2019
−37.1%
Volatility p.a.
51.3%
Largest decline
−98.3%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue8079817675717056
Gross profit–––40––––
Operating income-18-20-37-18-86-106-3650
EBITDA-7.2-7.9-24-4.9-73-94-2660
Net income-21-24-41-22-91-111-4140
Earnings per share-0.33-0.35-0.59-0.32-1.30-1.53-0.550.53
Balance sheet
Total assets859892616587503412359237
Liabilities49451526925525727425892
Equity365377348332246138101146
Cash250342514051606154
Long-term debt1511511511521521521520.0
Cash flow
Operating cash flow-3.50.3-9.0-0.59.9190.3-1.9
Capital expenditure-0.4-0.70.2-0.3-0.3-0.3-0.3-0.2
Free cash flow-3.9-0.4-8.8-0.79.618-0.1-2.0

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2020 at +25.4%, weakest 2022 at −73.2%. 1 of 6 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
5 Nov 2026$0.53
6 Aug 2026−$0.55
11 May 2026−$1.53
12 Mar 2026−$1.30
10 Nov 2025−$0.32
8 Aug 2025−$0.59
9 May 2025−$0.35
26 Feb 2025−$0.33
7 Nov 2024−$0.24
8 Aug 2024−$0.23
10 May 2024−$0.35
22 Feb 2024−$0.52

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€90m
Market cap in trading currency
$99.8m
Enterprise value
$20.8m
P/E
–
P/S
0.37
P/B
0.69
EV/Sales
0.08
EV/EBITDA
–
Earnings yield
–
FCF yield
25.8%

Results (last four quarters)

Revenue
$272m
Gross profit
–
EBITDA
−$133m
Net income
−$202m
Earnings per share
−$2.85
Revenue per share
$3.57
Revenue growth
−26.3%
Earnings growth
–

Profitability

Gross margin
–
Operating margin
-65.7%
Net margin
-74.2%
Return on equity
-84.6%
Return on assets
-85.1%

Balance sheet and cash flow

Cash
$79.0m
Cash per share
$1.04
Financial debt
$0
Debt/equity %
0
Current ratio
1.70
Book value per share
$1.91
Operating cash flow
$26.8m
Free cash flow
$25.7m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
–
Ex-dividend date
–

Shares and trading

Shares outstanding
76.2m
Volume
711,625
Avg. volume 3 months
435,054
Relative volume
1.7

Price and technicals

Price
$1.31
1 day
+1.6%
52-week high
$2.99
52-week low
$1.00
Distance to 52-week high
−56.2%
Distance to 52-week low
+31.5%
Distance to 50-day line
−20.7%
Distance to 200-day line
−20.9%
RSI (14)
37
Volatility 1M
99.0%

Performance

1 week
−13.2%
1 month
−24.7%
3 months
−17.6%
6 months
+1.6%
YTD
−45.2%
1 year
−37.9%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has HCAT performed since 07/2019?

$10,000 grew to $334 by 20 Nov 2026, which is −37.1% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is HCAT?

Volatility was 51.3% per year, measured on monthly returns. The largest decline from a peak was −98.3%, with the low in 04/2026.

How does HCAT compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.1% per year at 16.2% volatility, HCAT returned −37.1% at 51.3%. The correlation of monthly returns was 0.43; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Health Catalyst, Inc. (HCAT): Return and risk